Fifty Plus Scientific Enterprises Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 14-12-2024
- Paid Up Capital ₹ 0.10 M
as on 14-12-2024
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.50 M
as on 14-12-2024
- Revenue %
(FY 2021)
- Profit 12301.41%
(FY 2021)
- Ebitda 24855.47%
(FY 2021)
- Net Worth 5586.16%
(FY 2021)
- Total Assets 14216.80%
(FY 2021)
About Fifty Plus Scientific Enterprises
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.50 M.
Lakshmi Narayanan, Sidharth Menon, Arjun Ajayan, and One other member serve as directors at the Company.
- CIN/LLPIN
U31909KL2019PTC060204
- Company No.
060204
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Nov 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Fifty Plus Scientific Enterprises?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lakshmi Narayanan  | Managing Director | 05-Nov-2019 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sidharth Menon | Director | 05-Nov-2019 | Current |
| Arjun Ajayan | Director | 23-Sep-2020 | Current |
| Deepak Kuttiat | Director | 23-Sep-2020 | Current |
Financial Performance of Fifty Plus Scientific Enterprises.
Fifty Plus Scientific Enterprises Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 12301.41% increase in profit. The company's net worth Soared by an impressive increase of 5586.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fifty Plus Scientific Enterprises?
Unlock access to Fifty Plus Scientific Enterprises's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 04 Mar 2021 | ₹5.50 M | Open |
How Many Employees Work at Fifty Plus Scientific Enterprises?
Unlock and access historical data on people associated with Fifty Plus Scientific Enterprises, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fifty Plus Scientific Enterprises, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fifty Plus Scientific Enterprises's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
